News Column

NOVAVAX INC FILES (8-K) Disclosing Other Events, Financial Statements and Exhibits

June 11, 2014

Item 8.01. Other Events.

On June 11, 2014, Novavax, Inc. ("the Company") issued a press release announcing the closing of the previously announced public offering of 25,000,000 shares of common stock (the "Offering"), and that, pursuant to the underwriting agreement, dated June 5, 2014, with Citigroup Global Markets Inc. and J.P. Morgan Securities LLC as representative of the several underwriters listed on Schedule 1 thereto (the "Underwriters"), the Underwriters exercised their option to purchase an additional 3,750,000 shares of the Company's common stock, $0.01 par value per share ("Common Stock"). A copy of the Company's press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

An opinion dated June 11, 2014 regarding the legality of the issuance of the Common Stock in the Offering is filed as Exhibit 5.1 to this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits. Exhibit No. Description 5.1 Opinion of Ropes & Gray LLP. 23.1 Consent of Ropes & Gray LLP (included in Exhibit 5.1 above). 99.1 Press Release of Novavax, Inc. dated June 11, 2014.

For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: Edgar Glimpses

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters